Concepedia

V. Beliakouski

VB

2

Publications

59

Citations

2

H-Index

2010

Active since

Affiliations

Vita-Salute San Raffaele University(Current)

V. Beliakouski is an author at Vita-Salute San Raffaele University specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

2010–2021

2

Publications

2

Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy.

Tudor–Eliade Ciuleanu, M. Samarzjia, Y. Demidchik et al. · Journal of Clinical Oncology · 2010 · 44 citations

, , +18

LBA27 Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results from the NORSE study

Thomas Powles, V. Chistyakov, V. Beliakouski et al. · Annals of Oncology · 2021 · 15 citations

, , +7

Rows per page

1–2 of 2